Skip to main content
COTQF logo

Cotinga Pharmaceuticals Inc. (COTQF) Stock Analysis

DELISTED

What happened to Cotinga Pharmaceuticals Inc. (COTQF) stock?

Cotinga Pharmaceuticals Inc. (COTQF) no longer trades on public markets. The figures below are historical and are not a current quote.

Status:
Delisted — no longer trades
52-wk range: $0.0001 – $0.0001
Data from FMP · Methodology

For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Cotinga Pharmaceuticals Inc. (COTQF). Cotinga Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for cancer and unmet medical needs.

Last analyzed: Mar 17, 2026
Cotinga Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for cancer and unmet medical needs. The company is advancing its lead compound, COTI-2, targeting p53 mutations, alongside COTI-219, which targets mutant KRAS forms.

Cotinga Pharmaceuticals Inc. (COTQF) Healthcare & Pipeline Overview

Model self-rating on this text: 71% (not a measure of the evidence) Updated: Mar 17, 2026

COTQF OTC Market Information

COTQF trades on the OTC Other market tier of OTC Markets.

  • OTC Tier: OTC Other

More about this archive record

Can I still buy COTQF shares?

No. COTQF stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for COTQF elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before COTQF stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Cotinga Pharmaceuticals Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. Last updated: .

Data provided for informational purposes only.